SEC Form 4 · accession 0001205069-26-000005
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sven Wehrwein
Director
Period of report
Jul 28, 2026
Accepted (ET)
Jul 30, 2026 · 4:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 28, 2026 | M | 25,000 | $19.95 | A | 65,518 | D | |
| Common StockF1 | Jul 28, 2026 | S | 25,000 | $37.84 | D | 40,518 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (right to buy)F2 | $19.95 | Jul 28, 2026 | M | 25,000 | D | Nov 11, 2017 | Nov 11, 2026 | Non-qualified Stock Option (right to buy) | 25,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $37.73 to $39.04 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.